Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ilex, Ergomed Clinical Research Ltd. deal

CRO Ergomed acquired the operating assets of ILXO's clinical

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE